ADAM CHAPNICK
  • Adam Chapnick
    • Biography
    • Employment
    • Education
    • Academic Honours and research grants
    • Professional Administrative Experience
    • Advisory/Editorial Boards
    • Scholarly Assessments
    • Academic Associations
    • Additional Relevant Information
    • Adam Chapnick's Blog
    • Testimonials
  • Teaching & Learning
    • Teaching Philosophy
    • Teaching Experience
    • Supervisions and Thesis Defence Committees >
      • Supervisions
      • Thesis Defence Committees
    • Refereed Conference Presentations (Teaching & Learning)
    • Publications (Teaching & Learning)
    • Teaching Blogs >
      • Virtually Learning
      • The First Sabbatical
      • The Scholarly Edition
    • Other Teaching & Learning Activities
  • Research
    • Articles
    • Book Chapters
    • Books and Edited Collections >
      • Canada on the United Nations Security Council
      • The Harper Era in Canadian Foreign Policy
      • Manuel de rédaction à l’usage des militaires
      • John W. Holmes: An Introduction, Special Issue of International Journal
      • Academic Writing for Military Personnel​
      • Canada’s Voice: The Public Life of John Wendell Holmes
      • Canadas of the Mind
      • The Middle Power Project
      • Through Our Eyes: An Alumni History of the University of Toronto Schools, 1960-2000
    • Conference Presentations
    • Newspaper and Newsletter Commentaries
    • Publications in Conference Proceedings
    • Reports
    • Reviews
    • Teaching & Learning Publications
  • Public Speaking
    • Guest Lectures & Invited Speeches
    • Invited Workshops & Presentations (Teaching & Learning)
    • Arrange a Lecture, Workshop, or Presentation
  • Contact

Adam Chapnick's Blog

On Canada and COVAX

2/16/2021

3 Comments

 
I’ve been thinking a lot about the controversy that erupted last week when Canadians learned that we will be receiving 1.9 million doses of the Oxford-AstraZeneca vaccine from a global initiative known as COVAX before the end of June.
 
The CBC has provided a reasonable summary of the program and the controversy here.
 
To summarize, Canada has long been an anchor donor to international efforts to increase vaccination rates around the world.
 
So when the World Health Organization, the European Commission, and France launched a global campaign to improve access to COVID-19 vaccines, Ottawa signed up.
 
The program asks wealthy countries to pre-purchase enough doses to vaccinate up to 20% of their own populations as well as an equivalent number of people from poorer states.
 
The theory behind the program is that in order to end this pandemic, we need to inoculate an overwhelming majority of the world’s population before variants of COVID-19 emerge that the vaccines can’t handle (or at least can’t handle well).
 
Since we know that variants are more likely to arise when the virus is spreading uncontrollably, the best way to defeat COVID-19 is therefore not necessarily to vaccinate your own population first, but rather to get the number of cases around the world under sufficient control that we encounter fewer variants during the process of vaccination.
 
Theoretically, then, every country in the world should be a part of COVAX; money that wealthy countries have independently invested in vaccines should have been funnelled through the consortium; and the vaccination process should privilege not just individuals at the highest risk of death, but also locations where the virus is at the greatest risk of mutating.
 
In the real world, things have evolved differently.
 
The Trump administration refused to join COVAX and made vaccinating Americans its top priority.
 
Without the US, COVAX never stood a chance of reaching its full potential.
 
As a result, the Trudeau government did what successive Canadian governments have done since the end of the Second World War:
 
It looked out for itself (and its re-election prospects) by purchasing as many doses of as many vaccines as possible, but also joined COVAX to demonstrate Canada's continued commitment to a global solution to the ongoing pandemic.
 
Canadians believe in international cooperation, but we aren’t martyrs. If the Americans (and the Russians, and a handful of smaller countries) are intent on undermining the global effort, then we’re going to take care of ourselves, too.
 
Critics of Ottawa’s decision to accept the Oxford-AstraZeneca doses come from both sides of the political spectrum.
 
On the left, the Liberals have been accused of taking vaccines way from countries in greater need.
 
Personally, I find this suggestion spurious. For one, our government has been clear from the beginning that it would take its share, so no one is actually missing out.
 
More important, COVAX is not a charity. It was designed as an investment that was, at least theoretically, utterly consistent with the national interest.
 
Ottawa should continue to treat it that way, lest the Canadian public question our contribution in its entirety. The last thing we need is for future governments to propose a “Canada first” approach to international pandemic response.
 
Advocates from the political right want to keep the 1.9 million doses, but suggest that the Trudeau government should never have put Canadians in the position to need them in the first place.
 
That argument is also unconvincing.
 
This interview with the co-chair of Canada’s vaccine task force makes it clear that Ottawa, while imperfect, was hardly lackadaisical.
 
And again, an every-country-for-itself response to a global catastrophe should never be our starting point.
 
It seems to me that the Trudeau government’s real failure here has been in communication.
 
Consider the line Ottawa has used in response to questions about COVAX:
 
“Our top priority is that Canadians have vaccines.”
 
If that were truly the case, then we should not have invested in COVAX at all.
 
In reality, we have been trying to balance two competing priorities – (1) vaccinating Canadians as quickly as possible and (2) minimizing the capacity of the virus to mutate – ever since the United States decided to go it alone.
 
Apart from leveling with Canadians, Ottawa would do well to pursue two complementary policies:
 
First, along with other like-minded and committed multilateralists, we should be lobbying the Biden administration to invest in a successor to COVAX to respond to the next pandemic.
 
Second, and I suspect this is being done already, we should be developing a plan to share our excess vaccines once the situation at home is under control.
 
***
 
For a sense of Ottawa’s history of pragmatism in international affairs, take at look at this edited collection by the late Greg Donaghy. The essays by Denis Stairs and John English are particularly revealing.
 
I regret to note that Canadian foreign policy lost yet another treasured scholar recently: James Eayrs has passed away. For a sense of his outsized academic contribution to the study of Canada and its place in the world, check out this special issue of International Journal.

***
To be notified of my next blog post, follow me on Twitter @achapnick. 

You can subscribe to my newsletter at https://buttondown.email/achapnick
3 Comments
Rob Chambers
2/16/2021 08:56:38 am

Thanks for this, Adam. Again, rigorous analysis and depth with practical application. Very relevant.

Reply
Adam Chapnick
2/16/2021 12:03:34 pm

Thanks Rob!

Reply
Tom Dunne
2/17/2021 06:07:03 pm

Adam, thank you for your thoughts. I concur with your opinion.

I have found it striking down here in the US that COVAX was rarely discussed during the former administration, even by the media. Now, the fact that the US has joined is celebrated without due acknowledgement of their previous refusal to do so.

I agree that Canada must be pragmatic, and I fully support using the COVAX-purchased doses while awaiting production ramp-up of the other vaccines.

Reply



Leave a Reply.

    Author

    Adam Chapnick is a professor of defence studies at the Royal Military College of Canada (RMC). The views expressed here are entirely his own.

    Archives

    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019

    Categories

    All
    Canadian Foreign Policy
    Diplomacy
    Iran
    Trudeau

    RSS Feed

Proudly powered by Weebly
  • Adam Chapnick
    • Biography
    • Employment
    • Education
    • Academic Honours and research grants
    • Professional Administrative Experience
    • Advisory/Editorial Boards
    • Scholarly Assessments
    • Academic Associations
    • Additional Relevant Information
    • Adam Chapnick's Blog
    • Testimonials
  • Teaching & Learning
    • Teaching Philosophy
    • Teaching Experience
    • Supervisions and Thesis Defence Committees >
      • Supervisions
      • Thesis Defence Committees
    • Refereed Conference Presentations (Teaching & Learning)
    • Publications (Teaching & Learning)
    • Teaching Blogs >
      • Virtually Learning
      • The First Sabbatical
      • The Scholarly Edition
    • Other Teaching & Learning Activities
  • Research
    • Articles
    • Book Chapters
    • Books and Edited Collections >
      • Canada on the United Nations Security Council
      • The Harper Era in Canadian Foreign Policy
      • Manuel de rédaction à l’usage des militaires
      • John W. Holmes: An Introduction, Special Issue of International Journal
      • Academic Writing for Military Personnel​
      • Canada’s Voice: The Public Life of John Wendell Holmes
      • Canadas of the Mind
      • The Middle Power Project
      • Through Our Eyes: An Alumni History of the University of Toronto Schools, 1960-2000
    • Conference Presentations
    • Newspaper and Newsletter Commentaries
    • Publications in Conference Proceedings
    • Reports
    • Reviews
    • Teaching & Learning Publications
  • Public Speaking
    • Guest Lectures & Invited Speeches
    • Invited Workshops & Presentations (Teaching & Learning)
    • Arrange a Lecture, Workshop, or Presentation
  • Contact